Altrius Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Altrius Capital Management's PFE Position: Q1 2026 in Review
Altrius Capital Management increased its Pfizer (PFE) stake by 3.1% in Q1 2026, buying an estimated $163K and bringing the position to 203,089 shares worth $5.7M. The position accounts for 1.13% of the portfolio, ranked #45.
Altrius Capital Management first reported a position in PFE in Q2 2022 and has held it in 16 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Altrius Capital Management held 203,089 shares of Pfizer worth $5.7M as of Q1 2026.
- Altrius Capital Management bought 6,115 Pfizer shares in Q1 2026, an estimated $163K.
- Pfizer made up 1.13% of Altrius Capital Management's portfolio in Q1 2026, its #45 holding.
- Altrius Capital Management first reported a position in Pfizer in Q2 2022 and has held it in 16 quarters since.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Altrius Capital Management's 13F filing for Q1 2026, filed 5 May 2026.